Showing results (61-70 of 90) with videos related to
Sort By:
Pageof 9
Journal of Medicinal Chemistry|March 1, 1990
Preparation and anticonvulsant activity of a series of functionalized alpha-aromatic and alpha-heteroaromatic amino acidsH Kohn, K N Sawhney, P LeGall, et al.Journal of Medicinal Chemistry|May 1, 1987
Dihydropyridazinone cardiotonics: synthesis and inotropic activity of 5'-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)spiro[cycloalkane- 1,3'-[3H]indol]-2'(1'H)-onesD W Robertson, J H Krushinski, G D Pollock, et al.Neurochemistry International|October 1, 1993
Synthesis and evaluation of [125I]-(S)-iodozacopride, a high affinity radioligand for 5HT3 receptorsD R Gehlert, D A Schober, S L Gackenheimer, et al.Journal of Medicinal Chemistry|July 1, 1988
Electrophysiologic and antiarrhythmic activities of 4-amino-N-[2-(diethylamino)ethyl]-3,5-dimethylbenzamide, a sterically hindered procainamide analogueD W Robertson, E E Beedle, H Wilson, et al.Journal of Neurochemistry|February 1, 1993
Pharmacological and regional characterization of [3H]LY278584 binding sites in human brainA Abi-Dargham, M Laruelle, D T Wong, et al.Endocrinology|October 1, 1981
Tamoxifen aziridines: effective inactivators of the estrogen receptorD W Robertson, L L Wei, J R Hayes, et al.Journal of Medicinal Chemistry|April 1, 1987
Molecular structure of the dihydropyridazinone cardiotonic 1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-pyridazinyl)- 2H-indol-2-one, a potent inhibitor of cyclic AMP phosphodiesteraseD W Robertson, N D Jones, J H Krushinski, et al.The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
Chiral recognition of pinacidil and its 3-pyridyl isomer by canine cardiac and smooth muscle: antagonism by sulfonylureasM I Steinberg, S A Wiest, K M Zimmerman, et al.Journal of Medicinal Chemistry|September 1, 1986
Structure-activity relationships of (arylalkyl)imidazole anticonvulsants: comparison of the (fluorenylalkyl)imidazoles with nafimidone and denzimolD W Robertson, J H Krushinski, E E Beedle, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1995
Antagonism of serotonin3 (5-HT3) receptors within the blood-brain barrier prevents cisplatin-induced emesis in dogsJ S Gidda, D C Evans, M L Cohen, et al.Pageof 9